Release Date: 17/04/19 11:04 Summary: Changes to Executive Management & Variation to CN Facility Price Sensitive: Yes Download Document 170.95KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%